Gene Therapies That Could Transform Diseases Get Easier FDA Path – Bloomberg
Bloomberg |
Gene Therapies That Could Transform Diseases Get Easier FDA Path
Bloomberg Unlike traditional drugs, gene therapies are intended to be given once, transform the inner workings of the body and last for a lifetime. For regulators, the challenge is to find ways to get the new therapies to desperate patients while balancing the … FDA plans to speed path to approval for some gene therapies, starting with hemophilia Gottlieb: FDA Prepping for Push of New Gene and Cell Therapies Remarks by Commissioner Gottlieb to the Alliance for Regenerative Medicine's Annual Board Meeting |
